Allumiqs
Kent MacLean is the CEO & Director of Allumiqs, PhenoSwitch Bioscience, and Proteoform Scientific, companies specializing in providing multiomics, mass spectrometry services, and data-driven solutions to the biopharma and life sciences industries. Additionally, Kent is the Founder & Executive Director of Arcos Technologies Inc., specializing in Microsoft Business Solutions, and the Managing Director of NextWave Corporation, an investment and industry advisory firm. Prior to these roles, Kent held various financial and project management positions at companies such as Slemon Park Corporation and Lapointe Sweeney Carter.
This person is not in any teams
Allumiqs
Allumiqs is a strategic, outsourced CRO partner delivering multiomics, mass spectrometry, and data-driven solutions to help our biopharma and life sciences customers accelerate scientific discoveries and get to market faster.